AGI names director but profits slide

AGI Therapeutics, the Irish Stock Exchange-listed specialist drugs firm, has appointed David G Kelly as director and chief financial officer.

Mr Kelly, a chartered accountant, was most recently senior vice president of Warner Chilcott (formerly Galen).

AGI yesterday posted losses for 2005 of €5.2m, up from €3.1m in 2004.

You have reached your article limit. Already a subscriber? Sign in

Clubber TV and Irish Examiner logos in offer banner

Every Match. Every Story.

One Ultimate Bundle

No obligation. Ts&Cs apply.

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited